Search details
1.
Risk Factors for Immune Checkpoint Inhibitor Immunotherapy Toxicity Among Older Adults with Cancer.
Oncologist
; 28(8): e625-e632, 2023 08 03.
Article
in English
| MEDLINE | ID: mdl-37085156
2.
Association of medical comorbidities and cardiovascular disease with toxicity and survival among patients receiving checkpoint inhibitor immunotherapy.
Cancer Immunol Immunother
; 72(7): 2005-2013, 2023 Jul.
Article
in English
| MEDLINE | ID: mdl-36738310
3.
Mean platelet volume, thrombocytosis, and survival in non-small cell lung cancer patients treated with first-line pembrolizumab alone or with chemotherapy.
Cancer Immunol Immunother
; 72(7): 2067-2074, 2023 Jul.
Article
in English
| MEDLINE | ID: mdl-36795122
4.
Feasibility of an embedded palliative care clinic model for patients with an advanced thoracic malignancy.
Support Care Cancer
; 31(3): 167, 2023 Feb 14.
Article
in English
| MEDLINE | ID: mdl-36781558
5.
Immune checkpoint inhibitor-related thrombocytopenia: incidence, risk factors and effect on survival.
Cancer Immunol Immunother
; 71(5): 1157-1165, 2022 May.
Article
in English
| MEDLINE | ID: mdl-34618180
6.
Comparative assessment of manual chart review and ICD claims data in evaluating immunotherapy-related adverse events.
Cancer Immunol Immunother
; 70(10): 2761-2769, 2021 Oct.
Article
in English
| MEDLINE | ID: mdl-33625533
7.
Characteristics Associated With Functional Changes During Systemic Cancer Treatments: A Systematic Review Focused on Older Adults.
J Natl Compr Canc Netw
; 19(9): 1055-1062, 2021 04 15.
Article
in English
| MEDLINE | ID: mdl-33857918
8.
Bone Metastases, Skeletal-Related Events, and Survival in Patients With Metastatic Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.
J Natl Compr Canc Netw
; 19(8): 915-921, 2021 04 20.
Article
in English
| MEDLINE | ID: mdl-33878726
9.
Brief report: inhaled corticosteroid use and the risk of checkpoint inhibitor pneumonitis in patients with advanced cancer.
Cancer Immunol Immunother
; 69(11): 2403-2408, 2020 Nov.
Article
in English
| MEDLINE | ID: mdl-32728772
10.
Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medications.
BMC Cancer
; 20(1): 383, 2020 May 06.
Article
in English
| MEDLINE | ID: mdl-32375706
11.
Improving Access to Early Palliative Care Delivery for Patients With an Advanced Thoracic Malignancy Through an Embedded Oncopalliative Clinic Model.
JCO Oncol Pract
; 19(9): 777-785, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37279410
12.
Immune checkpoint inhibitor-induced hepatitis injury: risk factors, outcomes, and impact on survival.
J Cancer Res Clin Oncol
; 149(5): 2235-2242, 2023 May.
Article
in English
| MEDLINE | ID: mdl-36070148
13.
Impact of an Embedded Palliative Care Clinic on Healthcare Utilization for Patients With a New Thoracic Malignancy.
Front Oncol
; 12: 835881, 2022.
Article
in English
| MEDLINE | ID: mdl-35295997
14.
Serum Albumin: Early Prognostic Marker of Benefit for Immune Checkpoint Inhibitor Monotherapy But Not Chemoimmunotherapy.
Clin Lung Cancer
; 23(4): 345-355, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35131184
15.
Too Many Appointments: Assessing Provider and Nursing Perception of Barriers to Referral for Outpatient Palliative Care.
Palliat Med Rep
; 2(1): 137-145, 2021.
Article
in English
| MEDLINE | ID: mdl-34223513
16.
Substance Abuse Risk and Medication Monitoring in Patients with Advanced Lung Cancer Receiving Palliative Care.
J Pain Palliat Care Pharmacother
; 35(2): 91-99, 2021 Jun.
Article
in English
| MEDLINE | ID: mdl-34010103
17.
Checkpoint inhibitor immunotherapy toxicity and overall survival among older adults with advanced cancer.
J Geriatr Oncol
; 12(5): 813-819, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33627226
Results
1 -
17
de 17
1
Next >
>>